OTCMKTS:BSTG Biostage (BSTG) Stock Price, News & Analysis $4.45 0.00 (0.00%) (As of 07/24/2023) Add Compare Share Share Today's Range$4.45▼$4.4550-Day Range$4.45▼$4.4552-Week Range$4.45▼$4.45VolumeN/AAverage Volume1,847 shsMarket Capitalization$61.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Biostage alerts: Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About Biostage Stock (OTCMKTS:BSTG)Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.Read More BSTG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSTG Stock News HeadlinesJanuary 5, 2024 | investing.comHarvard Apparatus Regenerative Technology Inc (HRGN)August 22, 2023 | seekingalpha.comHRGN Harvard Apparatus Regenerative Technology Inc.September 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.July 20, 2023 | finance.yahoo.comBiostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)July 18, 2023 | finance.yahoo.comBiostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal DiseaseJuly 11, 2023 | benzinga.comBiostage CEO Awarded $1.07M Worth of Stock OptionsJune 13, 2023 | finance.yahoo.comBiostage to Host Investor CallMay 31, 2023 | finance.yahoo.comBiostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal DiseaseSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.May 16, 2023 | benzinga.comBiostage Stock (OTC:BSTG), Insider Trading ActivityApril 24, 2023 | sg.finance.yahoo.comBiostage, Inc. (BSTG) stock historical prices & data – Yahoo FinanceApril 23, 2023 | ca.finance.yahoo.comBiostage, Inc. (BSTG) Stock Historical Prices & Data - Yahoo FinanceApril 10, 2023 | finance.yahoo.comBiostage Appoints Ron Packard to Board of DirectorsApril 6, 2023 | finance.yahoo.comBiostage Announces $6 Million Financing to Advance Clinical TrialMarch 2, 2023 | finance.yahoo.comBiostage Announces Chairman and CEO TransitionFebruary 3, 2023 | msn.comRegenerative medicine developer Biostage cancels Nasdaq uplisting, public offeringJanuary 12, 2023 | finance.yahoo.comBiostage Amends CEO Employment AgreementDecember 28, 2022 | finance.yahoo.comBiostage, Inc. (OTC:BSTG) Q3 2022 Earnings Call TranscriptSee More Headlines Receive BSTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biostage and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2020Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolOTCMKTS:BSTG CUSIPN/A CIK1563665 Webwww.biostage.com Phone(744) 233-7300Fax774-233-7302Employees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,070,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-174.43% Debt Debt-to-Equity RatioN/A Current Ratio2.73 Quick Ratio2.73 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.26) per share Price / Book-17.12Miscellaneous Outstanding Shares13,882,000Free Float11,758,000Market Cap$61.77 million OptionableNot Optionable Beta-1.02 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Junli He (Age 49)CEO & Chairman Mr. Yu Hong (Age 50)Pres Comp: $158.06kDr. William L. Fodor Ph.D. (Age 64)Chief Scientific Officer Comp: $207.85kMr. Joseph L. Damasio Jr. (Age 49)Chief Financial Officer Dr. Shunfu Hu Ph.D.VP of Bus. Devel. & OperationsKey CompetitorsAVITA MedicalNASDAQ:RCELNeuroPaceNASDAQ:NPCEProfound MedicalNASDAQ:PROFBeauty HealthNASDAQ:SKINNevroNYSE:NVROView All Competitors BSTG Stock Analysis - Frequently Asked Questions How have BSTG shares performed this year? Biostage's stock was trading at $4.45 on January 1st, 2024. Since then, BSTG shares have increased by 0.0% and is now trading at $4.45. View the best growth stocks for 2024 here. How were Biostage's earnings last quarter? Biostage, Inc. (OTCMKTS:BSTG) issued its earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share for the quarter. How do I buy shares of Biostage? Shares of BSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Biostage own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biostage investors own include Fulcrum Therapeutics (FULC), Allena Pharmaceuticals (ALNA), VIVUS (VVUS), Aldeyra Therapeutics (ALDX), Arbutus Biopharma (ABUS), Akero Therapeutics (AKRO) and Ampliphi Biosciences (APHB). This page (OTCMKTS:BSTG) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biostage, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biostage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.